BioNexus KC: Children's Mercy Researcher Sees Opportunities To Improve Pediatric Outcomes
Pediatric medicine poses a unique dilemma. Historically, few studies have been conducted on children to determine the proper dose for many commonly prescribed medications. Finding the right drug and the correct amount often seems like trial and error. Steven Leeder, PharmD, PhD, Deputy Director of the Children’s Mercy Research Institute (CMRI), and a team of dedicated researchers are committed to solving this riddle with opportunistic research and big data to provide optimized and improved medicine for kids.
There are opportunities to develop dosage recommendations for children properly. In general, kids are healthy relative to adults, and when children are sick, taking additional blood samples for research may not be in the child’s best interest. This creates a bit of a dilemma – how can data be generated to improve the dosing of medications in children without that process being burdensome to the patients who can benefit? “Solving this dilemma requires creative approaches,” Leeder said.
Read the full article via BioNexus KC
Precision Therapeutics at Children's Mercy Research Institute